Findings for same-day nitric oxide levels and average levels for particulate matter in the preceding three days
TUESDAY, Sept. 6, 2022 (HealthDay News) — Air pollution is associated with significant increases in heart attacks among nonsmokers, according to a study presented at the European Society of Cardiology Congress 2022, held from Aug. 26 to 29 in Barcelona, Spain.
Insa de Buhr-Stockburger, M.D., from the Berlin Brandenburg Myocardial Infarction Registry, and colleagues examined the association between nitric oxide, particulate matter (PMâ‚â‚€), and weather variables with the incidence of myocardial infarction (MI) in Berlin. The analysis included 17,873 MI cases from 2008 to 2014.
The researchers found a highly significant, independent association between overall MI incidence and same-day mean values of nitric oxide concentrations and with the average PMâ‚â‚€ concentration over the preceding three days. MI incidence variation with same-day nitric oxide was 3.2 percent, and variation with PMâ‚â‚€ in the preceding three days was 4.8 percent. There was an inverse relationship between daily peak ambient temperature and MI incidence. No associations were seen for sunshine duration and precipitation. Nitric oxide and PMâ‚â‚€ pollution did not affect MI incidence in current smokers.
“The study indicates that dirty air is a risk factor for acute myocardial infarction and more efforts are needed to lower pollution from traffic and combustion,” de Buhr-Stockburger said in a statement. “Causation cannot be established by an observational study. It is plausible that air pollution is a contributing cause of myocardial infarction, given that nitric oxide and PMâ‚â‚€ promote inflammation, atherosclerosis is partly caused by inflammatory processes, and no associations were found in smokers.”
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD
Study Reveals Silicosis Rates Among Workers Fabricating Stone Countertops
Wildfires Now Top Source of Unhealthy Air for Pregnant Women in U.S.
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
Bimekizumab Well Tolerated, Efficacious Over Three Years in Axial Spondyloarthritis
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis